Danaher CorporationDHR

NYSEHealthcareLife Sciences Tools & Services$187.32+0.57%

A diversified life sciences and diagnostics company, it develops and manufactures instruments, consumables, and services used in bioprocessing, clinical diagnostics, and environmental applications. The company has expanded through acquisitions and portfolio optimization, sharpening its focus on higher-margin life sciences and laboratory tools. Investors track its exposure to biopharma research funding, hospital spending, and recurring revenue from consumables and service contracts.

Market Cap: $132.5B52W Range: $171.00 – $242.80

Congressional Interest in Danaher Corporation (DHR)

7 members of Congress have disclosed 24 trades in Danaher Corporation (DHR), a Healthcare company. The buy/sell breakdown shows 15 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.